Thomas Joseph Scanlan

US Patent:

20110070291, Mar 24, 2011

Filed:

Sep 9, 2010

Appl. No.:

12/878514

Inventors:

Joel R.L. Ehrenkranz - Salt Lake City UT, US
Thomas S. Scanlan - Portland OR, US

Assignee:

T*AMINE, LLC. - Salt Lake City UT

International Classification:

A61K 9/127
A61K 31/198
A61K 9/133
A61P 3/06
A61P 9/00
A61P 25/00
A61P 9/10
A61P 19/02
A61P 25/30

US Classification:

424450, 514567, 424490

Abstract:

Food or beverage compositions fortified with thyronines and/or thyronamines, processes for increasing T2, T1AM, and/or T0AM in a subject by administering a food or beverage composition that is fortified with at least one thyronine and/or thyronamine compound, and processes for promoting a healthy state by administering a food or beverage composition to a subject that is fortified with at least one thyronine and/or thyronamine compound. Increased levels of T2, T1AM, and/or T0AM in a subject can be associated with at least one of healthy cholesterol levels, healthy triglyceride levels, healthy blood sugar levels, cardiovascular health, healthy sleep patterns, healthy mood, healthy skin, healthy nails, or healthy endocrine function and/or a number of other markers of associated with general health and well-being.

US Patent:

20120065267, Mar 15, 2012

Filed:

Sep 8, 2011

Appl. No.:

13/228239

Inventors:

Joel R.L. Ehrenkranz - Salt Lake City UT, US
Thomas S. Scanlan - Portland OR, US

Assignee:

T*AMINE, LLC - Salt Lake City UT

International Classification:

A61K 31/195
A61P 3/06

US Classification:

514567

Abstract:

Compositions containing 3,5-L-T2 ((2S)-2-amino-3-[4-(4-hydroxyphenoxy)-3,5-diiodophenyl]propanoic acid) and methods for use thereof. Among other functions presented herein, 3,5-L-T2 can lower cholesterol via a mechanism that is independent of LDL receptor function. Disclosed compositions may include one or more additional active agents, such as, but not limited to, thyroid hormones other than 3,5-L-T2, cholesterol lowering agents, anti-diabetes agents, anti-hypertensives, vasodilators, inotropic agents, anti-coagulants, anti-anginals, anti-arrhythmics, leptin, leptin analogues, and adipokines, a vitamin and mineral composition. Disclosed methods include, but are not limited to, methods for treating hypercholesterolemia in a subject, and methods for treating at least one of metabolic syndrome, hypothyroidism, or thyroid suppression.